Development and validation of a nomogram for predicting in-hospital mortality of intensive care unit patients with liver cirrhosis

doi:10.4254/wjh.v16.i4.625

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1822)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

135

HTML

1131

Figures (1-6)

143

Tables (1-3)

118

Sum=1527

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

158

Sum=227

Apr 27, 2024 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Apr 27, 2024; 16(4): 625-639
Published online Apr 27, 2024. doi: 10.4254/wjh.v16.i4.625

Table 2 Baseline comparison between the two databases

Variables		All	MIMIC	eICU	P value
Variables		(n = 3571)	0 (n = 2730)	1 (n = 841)	P value
Hospital_expire_flag, n (%)	0	2827 (79.165)	2161 (79.158)	666 (79.191)	0.983
	1	744 (20.835)	569 (20.842)	175 (20.809)
Demographics
Age, median [IQR], yr		58.641 [51.114, 66.693]	59.043 [51.654, 67.468]	56.000 [50.000, 64.000]	< 0.001
Gender, n (%)	Female (0)	1351 (37.833)	1027 (37.619)	324 (38.526)	0.636
	Male (1)	2220 (62.167)	1703 (62.381)	517 (61.474)
Etiology and complications
Etiology, n (%)	Alcoholic (0)	1738 (48.670)	1448 (53.040)	290 (34.483)	< 0.001
	Others (1)	1833 (51.330)	1282 (46.960)	551 (65.517)
HE, n (%)	No (0)	2776(77.737)	2171 (79.524)	605 (71.938)	< 0.001
	Yes (1)	795(22.263)	559 (20.476)	236 (28.062)
VH, n (%)	No (0)	3147(88.127)	2407 (88.168)	740 (87.990)	0.889
	Yes (1)	424(11.873)	323 (11.832)	101 (12.010)
AKI_stage_max, n (%)	Without (0)	1077 (30.160)	646 (23.663)	431 (51.249)	< 0.001
	Stage Ⅰ (1)	497 (13.918)	333 (12.198)	164 (19.501)
	Stage Ⅱ (2)	808 (22.627)	779 (28.535)	29 (3.448)
	Stage Ⅲ (3)	1189 (33.296)	972 (35.604)	217 (25.803)
Comorbidities
Renal_disease, n (%)	No (0)	2784 (77.961)	2096 (76.777)	688 (81.807)	0.002
	Yes (1)	787 (22.039)	634 (23.223)	153 (18.193)
Diabetes, n (%)	No (0)	2514 (70.400)	1872 (68.571)	642 (76.338)	< 0.001
	Yes (1)	1057 (29.600)	858 (31.429)	199 (23.662)
COPD, n (%)	No (0)	3315 (92.831)	2563 (93.883)	752 (89.417)	< 0.001
	Yes (1)	256 (7.169)	167 (6.117)	89 (10.583)
HF, n (%)	No (0)	2899 (81.182)	2148 (78.681)	751 (89.298)	< 0.001
	Yes (1)	672 (18.818)	582 (21.319)	90 (10.702)
MI, n (%)	No (0)	3268 (91.515)	2462 (90.183)	806 (95.838)	< 0.001
	Yes (1)	303 (8.485)	268 (9.817)	35 (4.162)
Treatment
vasopressor, n (%)	No (0)	2199 (61.579)	1569 (57.473)	630 (74.911)	< 0.001
	Yes (1)	1372 (38.421)	1161 (42.527)	211 (25.089)
invasive_ventilation, n (%)	No (0)	2150 (60.207)	1499 (54.908)	651 (77.408)	< 0.001
	Yes (1)	1421 (39.793)	1231 (45.092)	190 (22.592)
RRT, n (%)	No (0)	3044 (85.242)	2314 (84.762)	730 (86.801)	0.145
	Yes (1)	527 (14.758)	416 (15.238)	111 (13.199)
Laboratory tests
Bicarbonate, median [IQR], mmol/L		22.000 [19.000, 25.000]	22.000 [19.000, 25.000]	22.000 [18.000, 25.000]	0.291
Calcium, median [IQR], mg/dL		8.300 [7.700, 8.800]	8.300 [7.700, 8.900]	8.200 [7.700, 8.700]	0.005
Chloride, median [IQR], mmol/L		102.000 [97.000, 107.000]	102.000 [97.000, 107.000]	102.000 [98.000, 107.000]	0.108
Sodium, median [IQR], mmol/L		137.000 [133.000, 140.000]	137.000 [133.000, 140.000]	136.000 [131.000, 140.000]	< 0.001
Potassium, median [IQR], mmol/L		4.100 [3.700, 4.700]	4.200 [3.700, 4.800]	4.100 [3.600, 4.600]	< 0.001
BUN, median [IQR], mg/dL		26.000 [15.000, 45.000]	26.000 [15.000, 45.000]	25.000 [14.000, 45.000]	0.49
Creatinine, median [IQR], mg/dL		1.200 [0.800, 2.100]	1.200 [0.800, 2.100]	1.250 [0.800, 2.200]	0.193
Albumin, median [IQR], g/dL		2.900 [2.400, 3.350]	3.000 [2.600, 3.400]	2.500 [2.100, 3.067]	< 0.001
ALT, median [IQR], IU/L		32.000 [20.000, 60.000]	31.000 [20.000, 59.500]	36.000 [23.000, 60.000]	0.001
AST, median [IQR], IU/L		65.000 [39.000, 126.000]	63.000 [38.000, 125.000]	70.000 [43.000, 130.000]	0.007
Bilirubin_total, median [IQR], mg/dL		2.623 [1.200, 6.400]	2.500 [1.100, 6.200]	3.100 [1.400, 7.000]	< 0.001
INR, median [IQR]		1.600 [1.300, 2.100]	1.600 [1.300, 2.100]	1.600 [1.300, 2.100]	0.272
Pt, median [IQR], sec		18.000 [14.800, 22.900]	17.800 [14.600, 22.700]	18.300 [15.500, 23.400]	0.005
Hemoglobin, median [IQR], g/dL		9.500 [8.000, 11.100]	9.500 [8.100, 11.100]	9.500 [8.000, 11.300]	0.88
Platelets, median [IQR], 10⁹/L		105.000 [67.000, 166.000]	108.000 [68.000, 170.000]	97.000 [63.000, 154.000]	< 0.001
WBC, median [IQR], 10⁹/L		9.100 [5.800, 13.700]	9.000 [5.800, 13.600]	9.400 [5.900, 14.300]	0.113
RDW, median [IQR], %		17.000 [15.200, 19.100]	16.800 [15.100, 18.900]	17.300 [15.500, 19.600]	< 0.001
Bicarbonate, median [IQR], mmol/L
Hr_mean, median [IQR]		87.182 [76.588, 99.122]	86.800 [76.237, 98.769]	89.029 [78.045, 100.000]	0.002
SBP_mean, median [IQR], mmHg		109.842 [101.208, 122.292]	110.120 [101.694, 122.500]	108.920 [99.750, 121.000]	0.002
Dbp_mean, median [IQR], mmHg		60.143 [53.750, 67.810]	60.320 [53.963, 68.038]	59.310 [53.225, 67.000]	0.031
Rr_mean, median [IQR], mmHg		18.363 [16.047, 21.286]	18.243 [15.958, 21.200]	18.640 [16.533, 21.896]	< 0.001
Prognostic scoring system
Meld, median [IQR]		16.588 [10.602, 24.153]	16.060 [10.225, 23.595]	17.887 [12.060, 26.087]	< 0.001
SOFA, median [IQR]		7.000 [5.000, 10.000]	8.000 [5.000, 10.000]	7.000 [5.000, 10.000]	0.017

HE: Hepatic encephalopathy; VH: Variceal hemorrhage; AKI: Acute kidney injury; COPD: Chronic obstructive pulmonary disease; HF: Heart failure; MI: Myocardial infarct; BUN: Blood urea nitrogen; ALT: Aminotransferase alanine; AST: Aminotransferase aspartate; INR: International Normalized Ratio; Pt: Prothrombin Time; WBC: White blood cells; RDW: Red cell distribution width; RRT: Renal replacement therapy; HR: Heart rate; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; RR: Respiratory rate; SOFA: Sequential Organ Failure Assessment; max: Maximum; MELD: Model for end-stage liver disease; IQR: Interquartile range; MIMIC-IV: Medical Information Mart for Intensive Care IV.

Citation: Tang XW, Ren WS, Huang S, Zou K, Xu H, Shi XM, Zhang W, Shi L, Lü MH. Development and validation of a nomogram for predicting in-hospital mortality of intensive care unit patients with liver cirrhosis. World J Hepatol 2024; 16(4): 625-639
URL: https://www.wjgnet.com/1948-5182/full/v16/i4/625.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i4.625